Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host extracellular matrix (ECM) is a complex, non-cellular network of proteins and carbohydrates that provides essential structural and biochemical support to surrounding cells (Frantz et al., 2010, Journal of Cell Science). It is composed of two primary classes of macromolecules: glycosaminoglycans (GAGs), often found as proteoglycans, and fibrous proteins such as collagen, elastin, fibronectin, and laminin (Theocharis et al., 2016, FEBS Journal). The ECM is not merely a passive scaffold; it actively regulates cellular behavior, including proliferation, survival, and migration, through interactions with receptors like integrins (Hynes, 2009, Science). Pathological remodeling of the ECM is a hallmark of several diseases, including organ fibrosis, where excessive protein deposition leads to organ failure, and cancer, where a stiffened or degraded matrix promotes tumor progression and metastasis (Lu et al., 2012, Journal of Cell Biology). Therapeutic interventions targeting the ECM include enzymatic degradation of excess matrix components, inhibition of fibrotic signaling to reduce protein deposition, and blocking cell-ECM adhesion to prevent inflammation or metastasis (Nallanthighal et al., 2019, Cancers). Because the ECM is ubiquitous, therapeutic strategies must often balance the need for localized remodeling with the risk of systemic structural instability (Bonnans et al., 2014, Nature Reviews Molecular Cell Biology).
Mechanisms of action include the enzymatic degradation of structural components like collagen or hyaluronan, the inhibition of intracellular signaling pathways (e.g., TGF-beta) that drive the synthesis of ECM proteins, and the use of antibodies to block the binding of cell-surface integrins to ECM ligands (Nallanthighal et al., 2019, Cancers; Bonnans et al., 2014, Nature Reviews Molecular Cell Biology).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host extracellular matrix proteins (ECM).